Efficacy Study of MM-093 in Rheumatoid Arthritis Patients on Methotrexate (MTX)

PHASE2CompletedINTERVENTIONAL
Enrollment

260

Participants

Timeline

Start Date

February 28, 2005

Conditions
Rheumatoid Arthritis
Interventions
DRUG

MM-093

Trial Locations (38)

13210

Arthritis Health Associates, Syracuse

16635

Altoona Center for Clinical Research, Duncansville

19090

Rheumatic Disease Associates, Willow Grove

21045

Rx Trials, Inc., Columbia

27609

CARE Center, Raleigh

North Carolina Arthritis and Allergy Care Center, Raleigh

28210

Arthritis Clinic and Carolina Bone and Joint PA, Charlotte

28801

Asheville Rheumatology and Osteoporosis Research Associates, Inc, Asheville

32174

International Medical Research, Ormond Beach

33143

Center for Arthritis and Rheumatic Diseases, South Miami

33180

Arthritis and Rheumatic Disease Specialties, Aventura

34239

Sarasota Arthritis Research Center, Sarasota

34471

Renstar Medical Research, Ocala

35294

University of Alabama, Birmingham

36111

Montgomery Rheumatology Associates, Montgomery

38104

The Arthritis Group, Memphis

45220

Veterans Administration Research Services, Cincinnati

46260

Rheumatology Associates, PC, Indianapolis

60016

Illinois Bone and Joint Institute, Morton Grove

60061

Deerbrook Medical Associates, Vernon Hills

62704

The Arthritis Center, Springfield

67208

Wichita Clinic, Wichita

68516

Arthritis Center of Nebraska, Lincoln

76708

Arthritis and Osteoporosis Clinic, Waco

77074

Houston Institute for Clinical Research, Houston

78705

Austin Rheumatology Research, Austin

80206

National Jewish Medical and Research Center, Denver

80230

Denver Arthritis Clinic, Denver

83814

Coeur d'Alene Arthritis Clinic, Coeur d'Alene

84132

University of Utah Division of Rheumatology, Salt Lake City

85012

ArthroCare, Arthritis Care and Research, Inc., Phoenix

85251

Radiant Research, Scottsdale

85253

Arizona Arthritis Research, PLC, Paradise Valley

89502

Arthritis Center of Reno, Reno

91786

Boling Clinical Trials, Upland

93454

Arthritis Medical Center of the Central Coast, Santa Maria

06606

New England Research Associates, Bridgeport

03301

Arthritis, Osteoporosis & Musculoskeletal Disease Center, Concord

Sponsors
All Listed Sponsors
lead

Merrimack Pharmaceuticals

INDUSTRY

NCT00105976 - Efficacy Study of MM-093 in Rheumatoid Arthritis Patients on Methotrexate (MTX) | Biotech Hunter | Biotech Hunter